A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6)

Diagnostic conversion to bipolar disorder in unipolar depressed patients participating in trials on antidepressants

(2017) J. Holmskov et al.   EUROPEAN PSYCHIATRY

Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressa

(2016) William V. Bobo et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD)

(2016) James J. Prisciandaro et al.   JOURNAL OF AFFECTIVE DISORDERS

Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS)

(2016) Søren D. Østergaard et al.   JOURNAL OF AFFECTIVE DISORDERS

Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton melancholia subscale (HAM-D 6 ) as outcome measure

(2016) Søren Dinesen Østergaard et al.   JOURNAL OF AFFECTIVE DISORDERS

The Validity of the Different Versions of the Hamilton Depression Scale in Separating Remission Rates of Placebo and Antidepressants in Clinical Trials of Major Depression

(2016) Phillip Raphael Kyle et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

(2016) André F. Carvalho et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Clinimetric Dilemmas in Outcome Scales for Mental Disorders

(2016) Per Bech   PSYCHOTHERAPY AND PSYCHOSOMATICS

Rating scales measuring the severity of psychotic depression

(2015) S. D. Østergaard et al.   ACTA PSYCHIATRICA SCANDINAVICA

PANSS-6: a brief rating scale for the measurement of severity in schizophrenia

(2015) S. D. Østergaard et al.   ACTA PSYCHIATRICA SCANDINAVICA

Clinical and psychometric validation of the psychotic depression assessment scale

(2015) Søren D. Østergaard et al.   JOURNAL OF AFFECTIVE DISORDERS

The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder

(2015) George I. Papakostas et al.   JOURNAL OF CLINICAL PSYCHIATRY

Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent

(2015) SHELDON PRESKORN et al.   Journal of Psychiatric Practice

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression

(2015) F Hieronymus et al.   MOLECULAR PSYCHIATRY

The responsiveness of the different versions of the Hamilton Depression Scale

(2015) Per Bech   World Psychiatry

Measuring treatment response in psychotic depression: The Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account

(2014) Søren D. Østergaard et al.   JOURNAL OF AFFECTIVE DISORDERS

Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC)

(2014) Søren D. Østergaard et al.   JOURNAL OF AFFECTIVE DISORDERS

The Hamilton Depression Scale (HAM-D) and the Montgomery–Åsberg Depression Scale (MADRS). A psychometric re-analysis of the European Genome-Based Therapeutic Drugs for Depression Study using Rasch analysis

(2014) Per Bech et al.   PSYCHIATRY RESEARCH

A short historical review of SCNP with special reference to the UKU

(2013) Per Bech et al.   ACTA NEUROPSYCHIATRICA

Measuring psychotic depression

(2013) S. D. Østergaard et al.   ACTA PSYCHIATRICA SCANDINAVICA

An item response theory evaluation of three depression assessment instruments in a clinical sample

(2013) Mats Adler et al.   BMC Medical Research Methodology

The Day-to-Day Acute Effect of Wake Therapy in Patients with Major Depression Using the HAM-D6 as Primary Outcome Measure: Results from a Randomised Controlled Trial

(2013) Klaus Martiny et al.   PLoS One

Clinimetrics and Clinical Psychometrics: Macro- and Micro-Analysis

(2012) Elena Tomba et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial

(2011) P. Bech et al.   ACTA PSYCHIATRICA SCANDINAVICA

Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression

(2011) Isabella Helmreich et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets

(2011) P. Bech et al.   JOURNAL OF AFFECTIVE DISORDERS

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

(2011) Emiliangelo Ratti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Why Has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?

(2010) Arif Khan et al.   CNS Neuroscience & Therapeutics

HAM-D17and HAM-D6Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder

(2010) P. Bech et al.   PHARMACOPSYCHIATRY

Is the antidepressive effect of second-generation antidepressants a myth?

(2009) P. Bech   PSYCHOLOGICAL MEDICINE

A validation analysis of two self-reported HAM-D6versions

(2008) P. Bech et al.   ACTA PSYCHIATRICA SCANDINAVICA

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

(2008) Michael R. Liebowitz et al.   CURRENT MEDICAL RESEARCH AND OPINION